Clinical trial
Esomeprazole In Patients With Gastric Acid Hypersecretory States Including…
NCT00079833 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00079833 |
|---|---|
| Title | Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome |
| Official title | A Phase III, Multicenter, Open-Label Study To Evaluate the Control of Gastric Acid Secretion With Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome For 12 Months |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Zollinger-Ellison Syndrome |
| Intervention type | Drug |
| Interventions | Esomeprazole magnesium (Nexium) |
| Enrollment | 25 |
| Start date | Nov 1, 2003 |
| Completion | Jul 1, 2005 |
| First posted | Mar 17, 2004 |
| Last update posted | Nov 19, 2010 |
| Countries | France, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: